3-Methylbutyrfentanyl

From WikiMD's WELLNESSPEDIA

Synthetic opioid analgesic

3-Methylbutyrfentanyl

3-Methylbutyrfentanyl




Chemical nomenclature
IUPAC name N-(1-(2-phenylethyl)piperidin-4-yl)-N-(3-methylbutanoyl)propanamide










Identifiers
CAS Number 14188-81-9
PubChem 44469364


ChemSpider 23274847



ChEMBL 2106060
Chemical data


Chemical formula C23H32N2O1


SMILES CCC(C)C(=O)N(C(=O)CC)C1CCN(CC1)CCc2ccccc2




3-Methylbutyrfentanyl is a synthetic opioid analgesic that is an analog of fentanyl. It is a potent agonist of the mu-opioid receptor, similar to other fentanyl analogs, and is used in research settings to study the effects of opioid receptor activation.

Chemical structure and properties[edit]

3-Methylbutyrfentanyl is chemically similar to fentanyl, with the primary difference being the substitution of a 3-methylbutyryl group for the propionyl group found in fentanyl. This modification results in changes to its pharmacokinetic and pharmacodynamic properties.

Pharmacology[edit]

As a potent mu-opioid receptor agonist, 3-Methylbutyrfentanyl produces effects typical of opioids, including analgesia, euphoria, sedation, and respiratory depression. The potency and efficacy of 3-Methylbutyrfentanyl in activating the mu-opioid receptor are comparable to those of fentanyl, making it a subject of interest in opioid research.

Legal status[edit]

Due to its structural similarity to fentanyl and its potential for abuse, 3-Methylbutyrfentanyl is classified as a controlled substance in many jurisdictions. It is often regulated under analog laws that control substances similar to those already scheduled.

Synthesis[edit]

The synthesis of 3-Methylbutyrfentanyl involves the acylation of the piperidine nitrogen in the fentanyl structure with 3-methylbutyryl chloride. This chemical reaction is typically carried out under controlled laboratory conditions due to the potency and potential hazards associated with fentanyl analogs.

Related compounds[edit]

See also[edit]

Gallery[edit]

3-Methylbutyrfentanyl[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.